| RLT Formulation Project Leader |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Rug 03, 2024 |
| RLT Analytical Product Project Leader (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Lie 11, 2024 |
| RLT Analytical Expert (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Lie 11, 2024 |
| RLT Drug Product Project Lead (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Lie 11, 2024 |
| Medical Advisor |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Lie 15, 2024 |
| Renal Medical Lead |
Seoul |
South Korea |
International |
Innovative Medicines |
Research & Development |
Rug 01, 2024 |
| Medical Scientific Liaison |
İstanbul Kavacık |
Turkey |
International |
Innovative Medicines |
Research & Development |
Rug 26, 2024 |
| Medical Lead Oncology |
Mumbai (Head Office) |
India |
International |
Innovative Medicines |
Research & Development |
Rug 16, 2024 |
| Medical Science Liaison (MSL), Czech Republic |
Prague |
Czech Republic |
International |
Innovative Medicines |
Research & Development |
Rug 27, 2024 |
| Medical Science Liaison, Immunology |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Research & Development |
Rug 30, 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Sr. Medical Science Liaison, ASCVD |
Seoul |
South Korea |
International |
Innovative Medicines |
Research & Development |
Rug 05, 2024 |
| Franchise Medical Head – Cardiovascular and Metabolism |
Seoul |
South Korea |
International |
Innovative Medicines |
Research & Development |
Spa 07, 2024 |
| Medical Science Liaison |
West Bengal |
India |
International |
Innovative Medicines |
Research & Development |
Rug 02, 2024 |
| Medical Science Liaison Neuro |
Ekaterinburg |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
Lie 25, 2024 |
| Medical Advisor In Market Brands |
Vilvoorde |
Belgium |
International |
Innovative Medicines |
Research & Development |
Spa 03, 2024 |
| Associate, TA Medical (General Medicines) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Spa 07, 2024 |
| Medical Science Liaison Immunology |
Field Force (England / Wales) |
United Kingdom |
International |
Innovative Medicines |
Research & Development |
Spa 10, 2024 |
| Medical Head Oncology |
Milano |
Italy |
International |
Innovative Medicines |
Research & Development |
Spa 14, 2024 |
| Senior Lead, TA Medical（General Medicines） |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Gegužė 27, 2024 |
| Lead, Medical Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 02, 2024 |
| Lead, RWE and Evidence Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 10, 2024 |
| Associate/Manager, MSL（Oncology） |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Lie 22, 2024 |
| Associate/Manager, MSL (Cardiovascular) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Rugp 20, 2024 |
| Medical Field Trainer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Rugp 29, 2024 |
| Group Manager, MSL |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
Rug 05, 2024 |
| Medical Science Liaison Hemato (Siberia) |
Novosibirsk |
Russian Fed. |
International |
Innovative Medicines |
Research & Development |
Rug 20, 2024 |
| MSL Manager - Hematology |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Gegužė 14, 2024 |
| Medical Science Liaison |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Research & Development |
Rugp 08, 2024 |
| Medical Advisor |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Rug 11, 2024 |
| (Senior) MSL Manager, LC |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Rug 18, 2024 |
| (Sr.) Medical Advisor, LC |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
Spa 18, 2024 |
| Senior Medical Information Manager 2 |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Operations |
CTS |
Research & Development |
Bal 23, 2024 |
| Sr. Automation Engineer |
Carlsbad |
USA |
Operations |
CTS |
Research & Development |
Rugp 02, 2024 |
| Principal RWE Research Analyst |
Hyderabad (Office) |
India |
Operations |
CTS |
Research & Development |
Gegužė 14, 2024 |
| Principal Scientific Writer |
Hyderabad (Office) |
India |
Operations |
CTS |
Research & Development |
Rug 03, 2024 |
| Clinical Laboratory Scientist, Generalist |
Carlsbad |
USA |
Operations |
Innovative Medicines |
Research & Development |
Gegužė 17, 2024 |
| Principal RWE Research Analyst |
Hyderabad (Office) |
India |
Operations |
CTS |
Research & Development |
Bir 06, 2024 |
| Clinical Project Manager |
Hyderabad (Office) |
India |
Operations |
CTS |
Research & Development |
Rug 03, 2024 |
| Team Lead Medical Communications (Scientific Engagements) |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Operations |
CTS |
Research & Development |
Spa 09, 2024 |
| Senior Specialist - Automation Engineer |
Sasayama |
Japan |
Operations |
|
Research & Development |
Lie 16, 2024 |
| Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Bal 25, 2024 |
| Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Spa 17, 2024 |
| Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Spa 17, 2024 |
| Medical Science Liaison Onc Prostate Radioligand Therapies DFW or North |
Remote |
USA |
US |
Innovative Medicines |
Research & Development |
Bir 05, 2024 |
| Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |